234 related articles for article (PubMed ID: 34671931)
1. Long non-coding RNA HOXA-AS3 facilitates the malignancy in colorectal cancer by miR-4319/SPNS2 axis.
Jiang Y; Yu XY; Sun HX; Gu XY; Geng JS
J Physiol Biochem; 2021 Nov; 77(4):653-666. PubMed ID: 34671931
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p.
Zhao Y; Yao R
Bioengineered; 2021 Dec; 12(1):8724-8737. PubMed ID: 34698001
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding HOXA-AS3 contributes to osteosarcoma progression through the miR-1286/TEAD1 axis.
Xiao X; Liu M; Xie S; Liu C; Huang X; Huang X
J Orthop Surg Res; 2023 Sep; 18(1):730. PubMed ID: 37752588
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.
Li ZK; Gao LF; Zhu XA; Xiang DK
Biochem Genet; 2021 Oct; 59(5):1158-1172. PubMed ID: 33687636
[TBL] [Abstract][Full Text] [Related]
6. HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis.
Zeng C; Ye S; Chen Y; Zhang Q; Luo Y; Gai L; Luo B
J Immunol Res; 2021; 2021():9289719. PubMed ID: 34988230
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
8. LncRNA
Tong Y; Wang M; Dai Y; Bao D; Zhang J; Pan H
Hum Gene Ther Clin Dev; 2019 Sep; 30(3):129-141. PubMed ID: 30963785
[TBL] [Abstract][Full Text] [Related]
9. Tumour-regulatory role of long non-coding RNA HOXA-AS3.
Chong ZX; Ho WY; Yeap SK
Prog Biophys Mol Biol; 2024 Jul; 189():13-25. PubMed ID: 38593905
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA HOXA-AS3 Suppresses the Progression of Atherosclerosis via Sponging miR-455-5p.
Chi K; Zhang J; Sun H; Liu Y; Li Y; Yuan T; Zhang F
Drug Des Devel Ther; 2020; 14():3651-3662. PubMed ID: 32982172
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lncRNA HOXA-AS3 in cervical cancer by targeting miR-29a-3p and its regulatory effect on tumor progression.
Xu H; Tang Y; He C; Tian Y; Ni R
J Obstet Gynaecol Res; 2022 Oct; 48(10):2594-2602. PubMed ID: 35817473
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269.
Zhang TT; Chen HP; Yu SY; Zhao SP
Hum Exp Toxicol; 2022; 41():9603271221093630. PubMed ID: 35537198
[TBL] [Abstract][Full Text] [Related]
13. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
14. SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway.
Gu X; Jiang Y; Xue W; Song C; Wang Y; Liu Y; Cui B
Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):861-871. PubMed ID: 31206801
[TBL] [Abstract][Full Text] [Related]
15. The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases.
Yao Q; Wang C; Wang Y; Zhang X; Jiang H; Chen D
Clin Transl Oncol; 2022 Dec; 24(12):2342-2350. PubMed ID: 35986859
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
18. Suppressing LncRNA HOXA-AS3 by CRISPR-dCas9 inhibits pancreatic cancer development.
Zhang X; Zhu H; Qu X; Yu Z; Zhang J
J Cancer; 2021; 12(21):6439-6444. PubMed ID: 34659534
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells.
Gao Z; Zhou H; Wang Y; Chen J; Ou Y
J Cell Biochem; 2020 Jan; 121(1):332-343. PubMed ID: 31222825
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
